查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
轉錄組定序市場 - 全球市場佔有率和排名、總收入、需求預測（2025-2031）
市場調查報告書
商品編碼
1682839

轉錄組定序市場 - 全球市場佔有率和排名、總收入、需求預測（2025-2031）

Transcriptome Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球轉錄組定序市場規模估計為 25.7111 億美元，預計到 2031 年將達到 60.7262 億美元，2025-2031 年預測期內的複合年成長率為 14.17%。

2024 年北美市場規模為 10.3543 億美元，預計到 2031 年將達到 24.293 億美元，預測期內（2025-2031 年）的複合年成長率為 14.1%。

2024 年亞太市場規模價值 6.7421 億美元，預計到 2031 年將達到 17.2486 億美元，預測期內（2025-2031 年）的複合年成長率為 15.42%。

2024 年歐洲市場規模價值 8.0213 億美元，預計到 2031 年將達到 18.0727 億美元，2025-2031 年預測期內的複合年成長率為 13.4%。

全球轉錄組定序定序的主要企業包括 Illumina、Thermo Fisher Scientific、Eurofins Scientific、Roche、Bio-Rad、Agilent Technologies、LabCorp、QIAGEN、Pacific Biosciences、Azenta、BGI Genomics、Novogene、Macrogen、上海紫江生物科技、清科生物技術等。 2024年，全球前五大公司以收益為準約佔66.47%的市佔率。

本報告對全球轉錄組定序市場進行了深入分析，包括各地區的市場規模及預測、主要企業的排名、市場佔有率等。

目錄

第1章 市場概況

  • 轉錄組定序產品介紹
  • 全球轉錄組定序市場規模預測（2020-2031）
  • 轉錄組定序序市場趨勢與促進因素
    • 轉錄組定序產業趨勢
    • 轉錄組定序序市場促進因素與機會
    • 轉錄組定序市場挑戰
  • 先決條件和限制
  • 研究目標
  • 考慮年數

第2章 公司競爭力分析

  • 全球轉錄組定序公司收益排名（2024年）
  • 全球轉錄組定序公司收益（2020-2025）
  • 轉錄組定定序製造地及主要企業總部分佈
  • 轉錄組定序市場的競爭分析
    • 轉錄組定序序市場集中度（2020-2025）
    • 全球轉錄組定序收益排名前 5 位和前 10 位的公司（2024 年）
    • 全球主要企業：依公司類型（一級、二級、三級）（基於截至 2024 年的轉錄組定序收益）
  • 合併、收購和擴張

第3章 按類型分類

  • 簡介：按類型
    • 編碼RNA
    • 非編碼RNA
  • 全球轉錄組定序收入（按類型）
    • 全球轉錄組定序收入（按類型分類）（2020 年、2024 年、2031 年）
    • 全球轉錄組定序收入（按類型）（2020-2031）
    • 全球轉錄組定序收入（按類型）（2020-2031）

第 4 章 細分：按應用

  • 簡介：按應用
    • 生醫領域
    • 非醫學領域
  • 全球轉錄組定序收入（按應用）
    • 全球轉錄組定序收入（按應用分類）（2020 年、2024 年、2031 年）
    • 全球轉錄組定序收入（按應用分類）（2020-2031）
    • 全球轉錄組定序收入（按應用分類）（2020-2031）

第 5 章 細分：按地區

  • 全球轉錄組定序收入（按地區）
    • 全球轉錄組定序收入（按地區分類）（2020 年、2024 年、2031 年）
    • 全球轉錄組定序收入（按地區分類）（2020-2025）
    • 全球轉錄組定序收入（按地區） (2026-2031)
    • 全球轉錄組定序收入（按地區分類）（2020-2031）
  • 北美洲
    • 北美轉錄組定序定序（2020-2031）
    • 北美轉錄組定序收入（按國家/地區分類）
  • 歐洲
    • 歐洲轉錄組定序收入（2020-2031）
    • 歐洲轉錄組定定序收入（按國家/地區分類）（2024 年和 2031 年）
  • 亞太地區
    • 亞太地區轉錄組定序收入（2020-2031）
    • 亞太地區轉錄組定序收入（按地區分類）（2024 年和 2031 年）
  • 南美洲
    • 南美洲轉錄組定序定序（2020-2031）
    • 南美洲轉錄組定序收入（按國家/地區分類）
  • 中東和非洲
    • 中東和非洲轉錄組定序定序（2020-2031）
    • 中東和非洲轉錄組定序收入（按國家/地區分類）（2024 年和 2031 年）

第6章 分部：主要國家/地區

  • 主要國家/地區轉錄組定序銷售成長趨勢（2020、2024、2031）
  • 主要國家/地區轉錄組定序收入（2020-2031）
  • 美國
    • 美國轉錄組定序收入（2020-2031）
    • 美國轉錄組定定序收入（按類型分類）（2024 年和 2031 年）
    • 美國轉錄組定序收入（按應用分類）（2024 年和 2031 年）
  • 歐洲
    • 歐洲轉錄組定序收入（2020-2031）
    • 歐洲轉錄組定定序收入（按類型分類）（2024 年和 2031 年）
    • 歐洲轉錄組定定序收入（按應用分類） (2024 年和 2031 年)
  • 中國
    • 中國轉錄組定序定序（2020-2031）
    • 中國轉錄組定序收入（按類型）（2024 年和 2031 年）
    • 中國轉錄組定序收入（按應用分類） (2024 年和 2031 年)
  • 日本
    • 日本轉錄組定序銷售額（2020-2031）
    • 日本轉錄組定序收入（按類型）（2024 年和 2031 年）
    • 日本轉錄組定序收入（按應用分類）（2024 年和 2031 年）
  • 韓國
    • 韓國轉錄組定序收入（2020-2031）
    • 韓國轉錄組定序收入（按類型）（2024 年和 2031 年）
    • 韓國轉錄組定定序收入（按應用分類） (2024 年和 2031 年)
  • 東南亞
    • 東南亞轉錄組定序收入（2020-2031）
    • 東南亞轉錄組定定序收入（按類型）（2024 年和 2031 年）
    • 東南亞轉錄組定序收入（按應用分類） (2024 年和 2031 年)
  • 印度
    • 印度轉錄組定序收入（2020-2031）
    • 印度轉錄組定序收入（按類型）（2024-2031）
    • 印度轉錄組定序收入（按應用分類）（2024 年和 2031 年）

第7章 公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Roche
  • Bio-Rad
  • Agilent Technologies
  • LabCorp
  • QIAGEN
  • Pacific Biosciences
  • Azenta
  • BGI Genomics
  • Novogene
  • Macrogen
  • Shanghai ZJ Bio-Tech
  • Tsingke Biotechnology

第8章產業鏈分析

  • 轉錄組定序產業鏈
  • 轉錄組定序上游分析
    • 主要成分
    • 製造成本結構
  • 分析流程
  • 下游分析（客戶分析）
  • 銷售模式及銷售管道

第9章調查結果與結論

第10章 附錄

The global market for Transcriptome Sequencing was estimated to be worth US$ 2,571.11 million in 2024 and is forecast to a readjusted size of US$ 6,072.62 million by 2031 with a CAGR of 14.17% during the forecast period 2025-2031.

North American market for Transcriptome Sequencing was valued at $ 1,035.43 million in 2024 and will reach $ 2,429.30 million by 2031, at a CAGR of 14.1% during the forecast period of 2025 through 2031.

Asia-Pacific market for Transcriptome Sequencing was valued at $ 674.21 million in 2024 and will reach $ 1,724.86 million by 2031, at a CAGR of 15.42% during the forecast period of 2025 through 2031.

Europe market for Transcriptome Sequencing was valued at $ 802.13 million in 2024 and will reach $ 1,807.27 million by 2031, at a CAGR of 13.4% during the forecast period of 2025 through 2031.

The global key companies of Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, BGI Genomics, Novogene, Macrogen, Shanghai ZJ Bio-Tech and Tsingke Biotechnology, etc. In 2024, the global five largest players hold a share approximately 66.47% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Transcriptome Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcriptome Sequencing by region & country, by Type, and by Application.

The Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Sequencing.

Market Segmentation

By Company

  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Roche
  • Bio-Rad
  • Agilent Technologies
  • LabCorp
  • QIAGEN
  • Pacific Biosciences
  • Azenta
  • BGI Genomics
  • Novogene
  • Macrogen
  • Shanghai ZJ Bio-Tech
  • Tsingke Biotechnology

Segment by Type

  • Coding RNA
  • Noncoding RNA

Segment by Application

  • Biomedical Field
  • Non-medical Field

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Nordic Countries
  • Rest of Europe
  • South America
  • Brazil
  • Rest of South America
  • Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Transcriptome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Transcriptome Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Transcriptome Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Transcriptome Sequencing Product Introduction
  • 1.2 Global Transcriptome Sequencing Market Size Forecast (2020-2031)
  • 1.3 Transcriptome Sequencing Market Trends & Drivers
    • 1.3.1 Transcriptome Sequencing Industry Trends
    • 1.3.2 Transcriptome Sequencing Market Drivers & Opportunity
    • 1.3.3 Transcriptome Sequencing Market Challenges
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Transcriptome Sequencing Players Revenue Ranking (2024)
  • 2.2 Global Transcriptome Sequencing Revenue by Company (2020-2025)
  • 2.3 Key Companies Transcriptome Sequencing Manufacturing Base Distribution and Headquarters
  • 2.4 Transcriptome Sequencing Market Competitive Analysis
    • 2.4.1 Transcriptome Sequencing Market Concentration Rate (2020-2025)
    • 2.4.2 Global 5 and 10 Largest Companies by Transcriptome Sequencing Revenue in 2024
    • 2.4.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
  • 2.5 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Coding RNA
    • 3.1.2 Noncoding RNA
  • 3.2 Global Transcriptome Sequencing Sales Value by Type
    • 3.2.1 Global Transcriptome Sequencing Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Transcriptome Sequencing Sales Value, by Type (2020-2031)
    • 3.2.3 Global Transcriptome Sequencing Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biomedical Field
    • 4.1.2 Non-medical Field
  • 4.2 Global Transcriptome Sequencing Sales Value by Application
    • 4.2.1 Global Transcriptome Sequencing Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Transcriptome Sequencing Sales Value, by Application (2020-2031)
    • 4.2.3 Global Transcriptome Sequencing Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Transcriptome Sequencing Sales Value by Region
    • 5.1.1 Global Transcriptome Sequencing Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Transcriptome Sequencing Sales Value by Region (2020-2025)
    • 5.1.3 Global Transcriptome Sequencing Sales Value by Region (2026-2031)
    • 5.1.4 Global Transcriptome Sequencing Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Transcriptome Sequencing Sales Value, 2020-2031
    • 5.2.2 North America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Transcriptome Sequencing Sales Value, 2020-2031
    • 5.3.2 Europe Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Transcriptome Sequencing Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Transcriptome Sequencing Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Transcriptome Sequencing Sales Value, 2020-2031
    • 5.5.2 South America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Transcriptome Sequencing Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Transcriptome Sequencing Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Transcriptome Sequencing Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Transcriptome Sequencing Sales Value, 2020-2031
    • 6.3.2 United States Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Transcriptome Sequencing Sales Value, 2020-2031
    • 6.4.2 Europe Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Transcriptome Sequencing Sales Value, 2020-2031
    • 6.5.2 China Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Transcriptome Sequencing Sales Value, 2020-2031
    • 6.6.2 Japan Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Transcriptome Sequencing Sales Value, 2020-2031
    • 6.7.2 South Korea Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Transcriptome Sequencing Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Transcriptome Sequencing Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Transcriptome Sequencing Sales Value, 2020-2031
    • 6.9.2 India Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Transcriptome Sequencing Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Illumina
    • 7.1.1 Illumina Profile
    • 7.1.2 Illumina Main Business
    • 7.1.3 Illumina Transcriptome Sequencing Products, Services and Solutions
    • 7.1.4 Illumina Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Illumina Recent Developments
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Profile
    • 7.2.2 Thermo Fisher Scientific Main Business
    • 7.2.3 Thermo Fisher Scientific Transcriptome Sequencing Products, Services and Solutions
    • 7.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Thermo Fisher Scientific Recent Developments
  • 7.3 Eurofins Scientific
    • 7.3.1 Eurofins Scientific Profile
    • 7.3.2 Eurofins Scientific Main Business
    • 7.3.3 Eurofins Scientific Transcriptome Sequencing Products, Services and Solutions
    • 7.3.4 Eurofins Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Eurofins Scientific Recent Developments
  • 7.4 Roche
    • 7.4.1 Roche Profile
    • 7.4.2 Roche Main Business
    • 7.4.3 Roche Transcriptome Sequencing Products, Services and Solutions
    • 7.4.4 Roche Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Roche Recent Developments
  • 7.5 Bio-Rad
    • 7.5.1 Bio-Rad Profile
    • 7.5.2 Bio-Rad Main Business
    • 7.5.3 Bio-Rad Transcriptome Sequencing Products, Services and Solutions
    • 7.5.4 Bio-Rad Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Bio-Rad Recent Developments
  • 7.6 Agilent Technologies
    • 7.6.1 Agilent Technologies Profile
    • 7.6.2 Agilent Technologies Main Business
    • 7.6.3 Agilent Technologies Transcriptome Sequencing Products, Services and Solutions
    • 7.6.4 Agilent Technologies Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Agilent Technologies Recent Developments
  • 7.7 LabCorp
    • 7.7.1 LabCorp Profile
    • 7.7.2 LabCorp Main Business
    • 7.7.3 LabCorp Transcriptome Sequencing Products, Services and Solutions
    • 7.7.4 LabCorp Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.7.5 LabCorp Recent Developments
  • 7.8 QIAGEN
    • 7.8.1 QIAGEN Profile
    • 7.8.2 QIAGEN Main Business
    • 7.8.3 QIAGEN Transcriptome Sequencing Products, Services and Solutions
    • 7.8.4 QIAGEN Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.8.5 QIAGEN Recent Developments
  • 7.9 Pacific Biosciences
    • 7.9.1 Pacific Biosciences Profile
    • 7.9.2 Pacific Biosciences Main Business
    • 7.9.3 Pacific Biosciences Transcriptome Sequencing Products, Services and Solutions
    • 7.9.4 Pacific Biosciences Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Pacific Biosciences Recent Developments
  • 7.10 Azenta
    • 7.10.1 Azenta Profile
    • 7.10.2 Azenta Main Business
    • 7.10.3 Azenta Transcriptome Sequencing Products, Services and Solutions
    • 7.10.4 Azenta Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Azenta Recent Developments
  • 7.11 BGI Genomics
    • 7.11.1 BGI Genomics Profile
    • 7.11.2 BGI Genomics Main Business
    • 7.11.3 BGI Genomics Transcriptome Sequencing Products, Services and Solutions
    • 7.11.4 BGI Genomics Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.11.5 BGI Genomics Recent Developments
  • 7.12 Novogene
    • 7.12.1 Novogene Profile
    • 7.12.2 Novogene Main Business
    • 7.12.3 Novogene Transcriptome Sequencing Products, Services and Solutions
    • 7.12.4 Novogene Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Novogene Recent Developments
  • 7.13 Macrogen
    • 7.13.1 Macrogen Profile
    • 7.13.2 Macrogen Main Business
    • 7.13.3 Macrogen Transcriptome Sequencing Products, Services and Solutions
    • 7.13.4 Macrogen Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Macrogen Recent Developments
  • 7.14 Shanghai ZJ Bio-Tech
    • 7.14.1 Shanghai ZJ Bio-Tech Profile
    • 7.14.2 Shanghai ZJ Bio-Tech Main Business
    • 7.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Products, Services and Solutions
    • 7.14.4 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Shanghai ZJ Bio-Tech Recent Developments
  • 7.15 Tsingke Biotechnology
    • 7.15.1 Tsingke Biotechnology Profile
    • 7.15.2 Tsingke Biotechnology Main Business
    • 7.15.3 Tsingke Biotechnology Transcriptome Sequencing Products, Services and Solutions
    • 7.15.4 Tsingke Biotechnology Transcriptome Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Tsingke Biotechnology Recent Developments

8 Industry Chain Analysis

  • 8.1 Transcriptome Sequencing Industrial Chain
  • 8.2 Transcriptome Sequencing Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Manufacturing Cost Structure
  • 8.3 Analysis Pipeline
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Transcriptome Sequencing Market Trends
  • Table 2. Transcriptome Sequencing Market Drivers & Opportunity
  • Table 3. Transcriptome Sequencing Market Challenges
  • Table 4. Global Transcriptome Sequencing Revenue by Company (2020-2025) & (US$ Million)
  • Table 5. Global Transcriptome Sequencing Revenue Market Share by Company (2020-2025)
  • Table 6. Key Companies Transcriptome Sequencing Manufacturing Base Distribution and Headquarters
  • Table 7. Global Transcriptome Sequencing Companies Market Concentration Ratio (CR5)
  • Table 8. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
  • Table 9. Mergers & Acquisitions, Expansion Plans
  • Table 10. Global Transcriptome Sequencing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 11. Global Transcriptome Sequencing Sales Value by Type (2020-2025) & (US$ Million)
  • Table 12. Global Transcriptome Sequencing Sales Value by Type (2026-2031) & (US$ Million)
  • Table 13. Global Transcriptome Sequencing Sales Market Share in Value by Type (2020-2025)
  • Table 14. Global Transcriptome Sequencing Sales Market Share in Value by Type (2026-2031)
  • Table 15. Global Transcriptome Sequencing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 16. Global Transcriptome Sequencing Sales Value by Application (2020-2025) & (US$ Million)
  • Table 17. Global Transcriptome Sequencing Sales Value by Application (2026-2031) & (US$ Million)
  • Table 18. Global Transcriptome Sequencing Sales Market Share in Value by Application (2020-2025)
  • Table 19. Global Transcriptome Sequencing Sales Market Share in Value by Application (2026-2031)
  • Table 20. Global Transcriptome Sequencing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 21. Global Transcriptome Sequencing Sales Value by Region (2020-2025) & (US$ Million)
  • Table 22. Global Transcriptome Sequencing Sales Value by Region (2026-2031) & (US$ Million)
  • Table 23. Global Transcriptome Sequencing Sales Value by Region (2020-2025) & (%)
  • Table 24. Global Transcriptome Sequencing Sales Value by Region (2026-2031) & (%)
  • Table 25. Key Countries/Regions Transcriptome Sequencing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 26. Key Countries/Regions Transcriptome Sequencing Sales Value, (2020-2025) & (US$ Million)
  • Table 27. Key Countries/Regions Transcriptome Sequencing Sales Value, (2026-2031) & (US$ Million)
  • Table 28. Illumina Basic Information List
  • Table 29. Illumina Description and Business Overview
  • Table 30. Illumina Transcriptome Sequencing Products, Services and Solutions
  • Table 31. Revenue (US$ Million) in Transcriptome Sequencing Business of Illumina (2020-2025)
  • Table 32. Illumina Recent Developments
  • Table 33. Thermo Fisher Scientific Basic Information List
  • Table 34. Thermo Fisher Scientific Description and Business Overview
  • Table 35. Thermo Fisher Scientific Transcriptome Sequencing Products, Services and Solutions
  • Table 36. Revenue (US$ Million) in Transcriptome Sequencing Business of Thermo Fisher Scientific (2020-2025)
  • Table 37. Thermo Fisher Scientific Recent Developments
  • Table 38. Eurofins Scientific Basic Information List
  • Table 39. Eurofins Scientific Description and Business Overview
  • Table 40. Eurofins Scientific Transcriptome Sequencing Products, Services and Solutions
  • Table 41. Revenue (US$ Million) in Transcriptome Sequencing Business of Eurofins Scientific (2020-2025)
  • Table 42. Eurofins Scientific Recent Developments
  • Table 43. Roche Basic Information List
  • Table 44. Roche Description and Business Overview
  • Table 45. Roche Transcriptome Sequencing Products, Services and Solutions
  • Table 46. Revenue (US$ Million) in Transcriptome Sequencing Business of Roche (2020-2025)
  • Table 47. Roche Recent Developments
  • Table 48. Bio-Rad Basic Information List
  • Table 49. Bio-Rad Description and Business Overview
  • Table 50. Bio-Rad Transcriptome Sequencing Products, Services and Solutions
  • Table 51. Revenue (US$ Million) in Transcriptome Sequencing Business of Bio-Rad (2020-2025)
  • Table 52. Bio-Rad Recent Developments
  • Table 53. Agilent Technologies Basic Information List
  • Table 54. Agilent Technologies Description and Business Overview
  • Table 55. Agilent Technologies Transcriptome Sequencing Products, Services and Solutions
  • Table 56. Revenue (US$ Million) in Transcriptome Sequencing Business of Agilent Technologies (2020-2025)
  • Table 57. Agilent Technologies Recent Developments
  • Table 58. LabCorp Basic Information List
  • Table 59. LabCorp Description and Business Overview
  • Table 60. LabCorp Transcriptome Sequencing Products, Services and Solutions
  • Table 61. Revenue (US$ Million) in Transcriptome Sequencing Business of LabCorp (2020-2025)
  • Table 62. LabCorp Recent Developments
  • Table 63. QIAGEN Basic Information List
  • Table 64. QIAGEN Description and Business Overview
  • Table 65. QIAGEN Transcriptome Sequencing Products, Services and Solutions
  • Table 66. Revenue (US$ Million) in Transcriptome Sequencing Business of QIAGEN (2020-2025)
  • Table 67. QIAGEN Recent Developments
  • Table 68. Pacific Biosciences Basic Information List
  • Table 69. Pacific Biosciences Description and Business Overview
  • Table 70. Pacific Biosciences Transcriptome Sequencing Products, Services and Solutions
  • Table 71. Revenue (US$ Million) in Transcriptome Sequencing Business of Pacific Biosciences (2020-2025)
  • Table 72. Pacific Biosciences Recent Developments
  • Table 73. Azenta Basic Information List
  • Table 74. Azenta Description and Business Overview
  • Table 75. Azenta Transcriptome Sequencing Products, Services and Solutions
  • Table 76. Revenue (US$ Million) in Transcriptome Sequencing Business of Azenta (2020-2025)
  • Table 77. Azenta Recent Developments
  • Table 78. BGI Genomics Basic Information List
  • Table 79. BGI Genomics Description and Business Overview
  • Table 80. BGI Genomics Transcriptome Sequencing Products, Services and Solutions
  • Table 81. Revenue (US$ Million) in Transcriptome Sequencing Business of BGI Genomics (2020-2025)
  • Table 82. BGI Genomics Recent Developments
  • Table 83. Novogene Basic Information List
  • Table 84. Novogene Description and Business Overview
  • Table 85. Novogene Transcriptome Sequencing Products, Services and Solutions
  • Table 86. Revenue (US$ Million) in Transcriptome Sequencing Business of Novogene (2020-2025)
  • Table 87. Novogene Recent Developments
  • Table 88. Macrogen Basic Information List
  • Table 89. Macrogen Description and Business Overview
  • Table 90. Macrogen Transcriptome Sequencing Products, Services and Solutions
  • Table 91. Revenue (US$ Million) in Transcriptome Sequencing Business of Macrogen (2020-2025)
  • Table 92. Macrogen Recent Developments
  • Table 93. Shanghai ZJ Bio-Tech Basic Information List
  • Table 94. Shanghai ZJ Bio-Tech Description and Business Overview
  • Table 95. Shanghai ZJ Bio-Tech Transcriptome Sequencing Products, Services and Solutions
  • Table 96. Revenue (US$ Million) in Transcriptome Sequencing Business of Shanghai ZJ Bio-Tech (2020-2025)
  • Table 97. Shanghai ZJ Bio-Tech Recent Developments
  • Table 98. Tsingke Biotechnology Basic Information List
  • Table 99. Tsingke Biotechnology Description and Business Overview
  • Table 100. Tsingke Biotechnology Transcriptome Sequencing Products, Services and Solutions
  • Table 101. Revenue (US$ Million) in Transcriptome Sequencing Business of Tsingke Biotechnology (2020-2025)
  • Table 102. Tsingke Biotechnology Recent Developments
  • Table 103. Raw Materials Key Suppliers Lists
  • Table 104. Transcriptome Sequencing Downstream Customers
  • Table 105. Research Programs/Design for This Report
  • Table 106. Key Data Information from Secondary Sources
  • Table 107. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Transcriptome Sequencing Product Picture
  • Figure 2. Global Transcriptome Sequencing Sales Value, 2020 VS 2025 VS 2031 (US$ Million)
  • Figure 3. Global Transcriptome Sequencing Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Transcriptome Sequencing Report Years Considered
  • Figure 5. Global Transcriptome Sequencing Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Transcriptome Sequencing Revenue in 2024
  • Figure 7. Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Coding RNA Picture
  • Figure 9. Noncoding RNA Picture
  • Figure 10. Global Transcriptome Sequencing Sales Value Market Share by Type, 2024 & 2031
  • Figure 11. Product Picture of Biomedical Field
  • Figure 12. Product Picture of Non-medical Field
  • Figure 13. Global Transcriptome Sequencing Sales Value Market Share by Application, 2024 & 2031
  • Figure 14. North America Transcriptome Sequencing Sales Value (2020-2031) & (US$ Million)
  • Figure 15. North America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 16. Europe Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 17. Europe Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 18. Asia Pacific Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 19. Asia Pacific Transcriptome Sequencing Sales Value by Region (%), 2024 VS 2031
  • Figure 20. South America Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. South America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Middle East & Africa Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Middle East & Africa Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 24. United States Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. United States Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 26. United States Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 27. Europe Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Europe Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 29. Europe Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 30. China Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. China Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 32. China Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Japan Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Japan Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Japan Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 36. South Korea Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. South Korea Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 38. South Korea Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Southeast Asia Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Southeast Asia Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Southeast Asia Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 42. India Transcriptome Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. India Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 44. India Transcriptome Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Transcriptome Sequencing Industrial Chain
  • Figure 46. Transcriptome Sequencing Manufacturing Cost Structure
  • Figure 47. Transcriptome Sequencing Manufacturing Cost Structure
  • Figure 48. Bottom-up and Top-down Approaches for This Report
  • Figure 49. Data Triangulation
  • Figure 50. Key Executives Interviewed